My long term goal is to establish an independent research career investigating the hormonal regulation of adipose tissue metabolism. During my graduate and postdoctoral training periods, I gained extensive research experience in the field of lipid metabolism. More recently, I acquired a broader perspective into mechanisms of obesity, diabetes, and cardiovascular biology while teaching undergraduate and graduate courses, delivering continuing education seminars to a variety of health professionals, and obtaining a Registered Dietitian credential. In pursuing the proposed research, I will develop new technical skills in studying adipose metabolism in animal models, in microarray technology, and in statistical analysis, while gaining additional knowledge in molecular endocrinology and adipose biology that will allow me to build an independent research program. Four prominent scholars with complementary expertise in growth hormone (GH) function and regulation of triacylglycerol (TAG) metabolism in adipocytes will serve as sponsors and cosponsors; a scientist with expertise in characterizing knockout mouse models of obesity and diabetes at Yale Mouse Metabolic Phenotyping Center will serve as a collaborator; and a statistican will serve as a consultant. The majority of the proposed research will be conducted in the laboratory of Dr. Kopchick, a molecular endocrinologist, at Ohio University. Visits to the laboratories of the cosponsors will occur as needed. As a model system, I will study a GH receptor/binding protein gene-disrupted (GHR -/-) mouse line previously generated in the Kopchick laboratory. Despite a dwarf appearance, GHR -/- mice have a higher percentage of body fat relative to body mass as compared to wild-type mice. The mechanism underlying this accumulation of excess adipose tissue has not been established. In this proposal, we will test the hypothesis that GH impacts adipose tissue in a depot-specific manner and will explore potential mechanisms for the increased fat mass in the GHR -/- mice. The specific goals of the proposed research are to 1) determine if GH influences TAG deposition or adipocyte differentiation in a depot-specific manner; 2) determine the mechanism for the increased fat mass in the absence of GH signaling; and 3) evaluate the role of perilipins, proteins surrounding the fat droplet, in GH-stimulated lipolysis. Accomplishment of this research will provide me with exceptional training in a new research area with untapped potential, as well as open multiple avenues of inquiry for the writing of competitive research proposals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
1K01DK064905-01A1
Application #
6825662
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Hyde, James F
Project Start
2004-08-01
Project End
2007-07-01
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
1
Fiscal Year
2004
Total Cost
$118,414
Indirect Cost
Name
Ohio University Athens
Department
Miscellaneous
Type
Other Domestic Higher Education
DUNS #
041077983
City
Athens
State
OH
Country
United States
Zip Code
45701
Berryman, Darlene E; List, Edward O; Palmer, Amanda J et al. (2010) Two-year body composition analyses of long-lived GHR null mice. J Gerontol A Biol Sci Med Sci 65:31-40
Palmer, Amanda J; Chung, Min-Yu; List, Edward O et al. (2009) Age-related changes in body composition of bovine growth hormone transgenic mice. Endocrinology 150:1353-60
Berryman, Darlene E; Christiansen, Jens Sandahl; Johannsson, Gudmundur et al. (2008) Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models. Growth Horm IGF Res 18:455-71
List, E O; Berryman, D E; Bower, B et al. (2008) The use of proteomics to study infectious diseases. Infect Disord Drug Targets 8:31-45
Berryman, Darlene E; Palmer, Amanda J; Gosney, Elahu S et al. (2007) Discovery and uses of pegvisomant: a growth hormone antagonist. Endokrynol Pol 58:322-9
List, Edward O; Berryman, Darlene E; Palmer, Amanda J et al. (2007) Analysis of mouse skin reveals proteins that are altered in a diet-induced diabetic state: a new method for detection of type 2 diabetes. Proteomics 7:1140-9
Kelder, Bruce; Berryman, Darlene E; Clark, Ryan et al. (2007) CIDE-A gene expression is decreased in white adipose tissue of growth hormone receptor/binding protein gene disrupted mice and with high-fat feeding of normal mice. Growth Horm IGF Res 17:346-51
Berryman, Darlene E; Dubale, Gauri M; Manchester, Diana S et al. (2006) Dietetics students possess negative attitudes toward obesity similar to nondietetics students. J Am Diet Assoc 106:1678-82
Berryman, Darlene E; List, Edward O; Kohn, Douglas T et al. (2006) Effect of growth hormone on susceptibility to diet-induced obesity. Endocrinology 147:2801-8